Global Influenza Virus Triple Test Card Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Influenza Virus Triple Test Card Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Fluorescent Immunoassay
- 1.3.3 Chromatographic Type
- 1.3.4 In Situ Hybridization
- 1.3.5 PCR Amplification Type
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Influenza Virus Triple Test Card Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.5 Global Influenza Virus Triple Test Card Market Size & Forecast
- 1.5.1 Global Influenza Virus Triple Test Card Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Influenza Virus Triple Test Card Sales Quantity (2021-2032)
- 1.5.3 Global Influenza Virus Triple Test Card Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Shenzhen Microprofit Biotech Co. Ltd.
- 2.1.1 Shenzhen Microprofit Biotech Co. Ltd. Details
- 2.1.2 Shenzhen Microprofit Biotech Co. Ltd. Major Business
- 2.1.3 Shenzhen Microprofit Biotech Co. Ltd. Influenza Virus Triple Test Card Product and Services
- 2.1.4 Shenzhen Microprofit Biotech Co. Ltd. Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Shenzhen Microprofit Biotech Co. Ltd. Recent Developments/Updates
- 2.2 Fisher Healthcare
- 2.2.1 Fisher Healthcare Details
- 2.2.2 Fisher Healthcare Major Business
- 2.2.3 Fisher Healthcare Influenza Virus Triple Test Card Product and Services
- 2.2.4 Fisher Healthcare Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Fisher Healthcare Recent Developments/Updates
- 2.3 Virax Biolabs
- 2.3.1 Virax Biolabs Details
- 2.3.2 Virax Biolabs Major Business
- 2.3.3 Virax Biolabs Influenza Virus Triple Test Card Product and Services
- 2.3.4 Virax Biolabs Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Virax Biolabs Recent Developments/Updates
- 2.4 Abbott Laboratories
- 2.4.1 Abbott Laboratories Details
- 2.4.2 Abbott Laboratories Major Business
- 2.4.3 Abbott Laboratories Influenza Virus Triple Test Card Product and Services
- 2.4.4 Abbott Laboratories Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Abbott Laboratories Recent Developments/Updates
- 2.5 Roche
- 2.5.1 Roche Details
- 2.5.2 Roche Major Business
- 2.5.3 Roche Influenza Virus Triple Test Card Product and Services
- 2.5.4 Roche Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Roche Recent Developments/Updates
- 2.6 Quidel Corp.
- 2.6.1 Quidel Corp. Details
- 2.6.2 Quidel Corp. Major Business
- 2.6.3 Quidel Corp. Influenza Virus Triple Test Card Product and Services
- 2.6.4 Quidel Corp. Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Quidel Corp. Recent Developments/Updates
- 2.7 BioFire Diagnostics
- 2.7.1 BioFire Diagnostics Details
- 2.7.2 BioFire Diagnostics Major Business
- 2.7.3 BioFire Diagnostics Influenza Virus Triple Test Card Product and Services
- 2.7.4 BioFire Diagnostics Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 BioFire Diagnostics Recent Developments/Updates
- 2.8 Cepheid
- 2.8.1 Cepheid Details
- 2.8.2 Cepheid Major Business
- 2.8.3 Cepheid Influenza Virus Triple Test Card Product and Services
- 2.8.4 Cepheid Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Cepheid Recent Developments/Updates
- 2.9 Luminex Corp.
- 2.9.1 Luminex Corp. Details
- 2.9.2 Luminex Corp. Major Business
- 2.9.3 Luminex Corp. Influenza Virus Triple Test Card Product and Services
- 2.9.4 Luminex Corp. Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Luminex Corp. Recent Developments/Updates
- 2.10 GenMark Diagnostics
- 2.10.1 GenMark Diagnostics Details
- 2.10.2 GenMark Diagnostics Major Business
- 2.10.3 GenMark Diagnostics Influenza Virus Triple Test Card Product and Services
- 2.10.4 GenMark Diagnostics Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 GenMark Diagnostics Recent Developments/Updates
- 2.11 DiaSorin Molecular
- 2.11.1 DiaSorin Molecular Details
- 2.11.2 DiaSorin Molecular Major Business
- 2.11.3 DiaSorin Molecular Influenza Virus Triple Test Card Product and Services
- 2.11.4 DiaSorin Molecular Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 DiaSorin Molecular Recent Developments/Updates
- 2.12 Seegene Inc.
- 2.12.1 Seegene Inc. Details
- 2.12.2 Seegene Inc. Major Business
- 2.12.3 Seegene Inc. Influenza Virus Triple Test Card Product and Services
- 2.12.4 Seegene Inc. Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Seegene Inc. Recent Developments/Updates
- 2.13 SD Biosensor
- 2.13.1 SD Biosensor Details
- 2.13.2 SD Biosensor Major Business
- 2.13.3 SD Biosensor Influenza Virus Triple Test Card Product and Services
- 2.13.4 SD Biosensor Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 SD Biosensor Recent Developments/Updates
- 2.14 Access Bio Inc.
- 2.14.1 Access Bio Inc. Details
- 2.14.2 Access Bio Inc. Major Business
- 2.14.3 Access Bio Inc. Influenza Virus Triple Test Card Product and Services
- 2.14.4 Access Bio Inc. Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Access Bio Inc. Recent Developments/Updates
- 2.15 SolGent Co. Ltd.
- 2.15.1 SolGent Co. Ltd. Details
- 2.15.2 SolGent Co. Ltd. Major Business
- 2.15.3 SolGent Co. Ltd. Influenza Virus Triple Test Card Product and Services
- 2.15.4 SolGent Co. Ltd. Influenza Virus Triple Test Card Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 SolGent Co. Ltd. Recent Developments/Updates
3 Competitive Environment: Influenza Virus Triple Test Card by Manufacturer
- 3.1 Global Influenza Virus Triple Test Card Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Influenza Virus Triple Test Card Revenue by Manufacturer (2021-2026)
- 3.3 Global Influenza Virus Triple Test Card Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Influenza Virus Triple Test Card by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Influenza Virus Triple Test Card Manufacturer Market Share in 2025
- 3.4.3 Top 6 Influenza Virus Triple Test Card Manufacturer Market Share in 2025
- 3.5 Influenza Virus Triple Test Card Market: Overall Company Footprint Analysis
- 3.5.1 Influenza Virus Triple Test Card Market: Region Footprint
- 3.5.2 Influenza Virus Triple Test Card Market: Company Product Type Footprint
- 3.5.3 Influenza Virus Triple Test Card Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Influenza Virus Triple Test Card Market Size by Region
- 4.1.1 Global Influenza Virus Triple Test Card Sales Quantity by Region (2021-2032)
- 4.1.2 Global Influenza Virus Triple Test Card Consumption Value by Region (2021-2032)
- 4.1.3 Global Influenza Virus Triple Test Card Average Price by Region (2021-2032)
- 4.2 North America Influenza Virus Triple Test Card Consumption Value (2021-2032)
- 4.3 Europe Influenza Virus Triple Test Card Consumption Value (2021-2032)
- 4.4 Asia-Pacific Influenza Virus Triple Test Card Consumption Value (2021-2032)
- 4.5 South America Influenza Virus Triple Test Card Consumption Value (2021-2032)
- 4.6 Middle East & Africa Influenza Virus Triple Test Card Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Influenza Virus Triple Test Card Sales Quantity by Type (2021-2032)
- 5.2 Global Influenza Virus Triple Test Card Consumption Value by Type (2021-2032)
- 5.3 Global Influenza Virus Triple Test Card Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Influenza Virus Triple Test Card Sales Quantity by Application (2021-2032)
- 6.2 Global Influenza Virus Triple Test Card Consumption Value by Application (2021-2032)
- 6.3 Global Influenza Virus Triple Test Card Average Price by Application (2021-2032)
7 North America
- 7.1 North America Influenza Virus Triple Test Card Sales Quantity by Type (2021-2032)
- 7.2 North America Influenza Virus Triple Test Card Sales Quantity by Application (2021-2032)
- 7.3 North America Influenza Virus Triple Test Card Market Size by Country
- 7.3.1 North America Influenza Virus Triple Test Card Sales Quantity by Country (2021-2032)
- 7.3.2 North America Influenza Virus Triple Test Card Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Influenza Virus Triple Test Card Sales Quantity by Type (2021-2032)
- 8.2 Europe Influenza Virus Triple Test Card Sales Quantity by Application (2021-2032)
- 8.3 Europe Influenza Virus Triple Test Card Market Size by Country
- 8.3.1 Europe Influenza Virus Triple Test Card Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Influenza Virus Triple Test Card Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Influenza Virus Triple Test Card Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Influenza Virus Triple Test Card Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Influenza Virus Triple Test Card Market Size by Region
- 9.3.1 Asia-Pacific Influenza Virus Triple Test Card Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Influenza Virus Triple Test Card Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Influenza Virus Triple Test Card Sales Quantity by Type (2021-2032)
- 10.2 South America Influenza Virus Triple Test Card Sales Quantity by Application (2021-2032)
- 10.3 South America Influenza Virus Triple Test Card Market Size by Country
- 10.3.1 South America Influenza Virus Triple Test Card Sales Quantity by Country (2021-2032)
- 10.3.2 South America Influenza Virus Triple Test Card Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Influenza Virus Triple Test Card Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Influenza Virus Triple Test Card Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Influenza Virus Triple Test Card Market Size by Country
- 11.3.1 Middle East & Africa Influenza Virus Triple Test Card Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Influenza Virus Triple Test Card Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Influenza Virus Triple Test Card Market Drivers
- 12.2 Influenza Virus Triple Test Card Market Restraints
- 12.3 Influenza Virus Triple Test Card Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Influenza Virus Triple Test Card and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Influenza Virus Triple Test Card
- 13.3 Influenza Virus Triple Test Card Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Influenza Virus Triple Test Card Typical Distributors
- 14.3 Influenza Virus Triple Test Card Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Influenza Virus Triple Test Card market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
The Influenza Virus Triple Test Card is a diagnostic tool used to detect influenza virus infection. It usually consists of a strip or card that is coated with specific antigens or antibodies. Using this test card can simultaneously detect influenza virus type A (including H1N1 and H3N2 subtypes) and influenza virus type B. When using the influenza virus triple test card, medical staff will take a patient"s throat swab or nasal swab sample and drop the sample on a test strip or card. If antigens or antibodies to the flu virus are present in the sample, they will bind to the corresponding antibodies or antigens on the test strip or card, resulting in a visible line or color reaction. According to the line or color change on the test strip or card, medical personnel can judge whether the patient is infected with influenza virus, so as to take corresponding treatment measures in time.
This report is a detailed and comprehensive analysis for global Influenza Virus Triple Test Card market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Influenza Virus Triple Test Card market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Influenza Virus Triple Test Card market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Influenza Virus Triple Test Card market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Influenza Virus Triple Test Card market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Influenza Virus Triple Test Card
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Influenza Virus Triple Test Card market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shenzhen Microprofit Biotech Co. Ltd., Fisher Healthcare, Virax Biolabs, Abbott Laboratories, Roche, Quidel Corp., BioFire Diagnostics, Cepheid, Luminex Corp., GenMark Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Influenza Virus Triple Test Card market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fluorescent Immunoassay
Chromatographic Type
In Situ Hybridization
PCR Amplification Type
Market segment by Application
Hospital
Clinic
Major players covered
Shenzhen Microprofit Biotech Co. Ltd.
Fisher Healthcare
Virax Biolabs
Abbott Laboratories
Roche
Quidel Corp.
BioFire Diagnostics
Cepheid
Luminex Corp.
GenMark Diagnostics
DiaSorin Molecular
Seegene Inc.
SD Biosensor
Access Bio Inc.
SolGent Co. Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Influenza Virus Triple Test Card product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Influenza Virus Triple Test Card, with price, sales quantity, revenue, and global market share of Influenza Virus Triple Test Card from 2021 to 2026.
Chapter 3, the Influenza Virus Triple Test Card competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Virus Triple Test Card breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Influenza Virus Triple Test Card market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza Virus Triple Test Card.
Chapter 14 and 15, to describe Influenza Virus Triple Test Card sales channel, distributors, customers, research findings and conclusion.